![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PRRG1 |
Gene summary for PRRG1 |
![]() |
Gene information | Species | Human | Gene symbol | PRRG1 | Gene ID | 5638 |
Gene name | proline rich and Gla domain 1 | |
Gene Alias | PRGP1 | |
Cytomap | Xp21.1 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | O14668 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5638 | PRRG1 | male-WTA | Human | Thyroid | PTC | 2.11e-25 | 2.88e-01 | 0.1037 |
5638 | PRRG1 | PTC01 | Human | Thyroid | PTC | 4.70e-13 | 1.85e-01 | 0.1899 |
5638 | PRRG1 | PTC04 | Human | Thyroid | PTC | 9.16e-04 | 1.03e-01 | 0.1927 |
5638 | PRRG1 | PTC05 | Human | Thyroid | PTC | 1.06e-15 | 5.80e-01 | 0.2065 |
5638 | PRRG1 | PTC06 | Human | Thyroid | PTC | 3.13e-29 | 5.30e-01 | 0.2057 |
5638 | PRRG1 | PTC07 | Human | Thyroid | PTC | 3.47e-25 | 4.55e-01 | 0.2044 |
5638 | PRRG1 | ATC13 | Human | Thyroid | ATC | 1.32e-06 | 8.76e-02 | 0.34 |
5638 | PRRG1 | ATC2 | Human | Thyroid | ATC | 6.70e-09 | 5.84e-01 | 0.34 |
5638 | PRRG1 | ATC5 | Human | Thyroid | ATC | 1.09e-02 | 9.59e-02 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Oral cavity | OSCC | ![]() |
Oral cavity | LP | ![]() |
Oral cavity | EOLP | ![]() |
Oral cavity | NEOLP | ![]() |
Esophagus | HGIN | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PRRG1 | SNV | Missense_Mutation | c.349N>A | p.Glu117Lys | p.E117K | O14668 | protein_coding | tolerated(0.22) | benign(0.01) | TCGA-D8-A1JA-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | PD | |
PRRG1 | SNV | Missense_Mutation | c.517N>C | p.Glu173Gln | p.E173Q | O14668 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-D8-A1JA-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | PD | |
PRRG1 | insertion | Frame_Shift_Ins | novel | c.169dupA | p.Thr57AsnfsTer2 | p.T57Nfs*2 | O14668 | protein_coding | TCGA-A8-A079-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | 5-fluorouracil | SD | ||
PRRG1 | deletion | Frame_Shift_Del | rs782098470 | c.394delN | p.Pro134HisfsTer19 | p.P134Hfs*19 | O14668 | protein_coding | TCGA-AN-A0AK-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
PRRG1 | SNV | Missense_Mutation | c.583N>A | p.Glu195Lys | p.E195K | O14668 | protein_coding | tolerated(0.92) | benign(0.021) | TCGA-C5-A1BI-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
PRRG1 | insertion | Frame_Shift_Ins | rs781858060 | c.393_394insC | p.Pro135ThrfsTer3 | p.P135Tfs*3 | O14668 | protein_coding | TCGA-EA-A3HS-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | ||
PRRG1 | deletion | Frame_Shift_Del | rs782098470 | c.394delN | p.Pro134HisfsTer19 | p.P134Hfs*19 | O14668 | protein_coding | TCGA-MA-AA42-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD | ||
PRRG1 | SNV | Missense_Mutation | novel | c.464N>A | p.Arg155His | p.R155H | O14668 | protein_coding | tolerated(0.22) | benign(0) | TCGA-5M-AAT6-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
PRRG1 | SNV | Missense_Mutation | novel | c.634C>T | p.Pro212Ser | p.P212S | O14668 | protein_coding | deleterious_low_confidence(0.01) | probably_damaging(0.994) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
PRRG1 | SNV | Missense_Mutation | c.551N>A | p.Ser184Asn | p.S184N | O14668 | protein_coding | tolerated(0.45) | benign(0.003) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |